<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
x
 

Reducing Uncertainty in Early Oncology with Patient-derived Systems

Marianne Baillargeon
Marianne Baillargeon
May 29, 2026
Reducing Uncertainty in Early Oncology with Patient-derived Systems
SHARE

Originally posted in Drug Discovery News on January 26, 2026, by Marianne Baillargeon

Integrating patient-derived xenografts and organoids can help researchers identify responsive tumor subsets, anticipate resistance, and strengthen translational confidence before clinical testing.

Download PDF

Cite this Article

Baillargeon, M., (2026) Reducing Uncertainty in Early Oncology with Patient-derived Systems - Crown Bioscience. https://blog.crownbio.com/reducing-uncertainty-in-early-oncology-with-patient-derived-systems